Mobility Limitation Clinical Trial
Official title:
An Exploratory Study to Evaluate the Relationship Between Measures of Lower-extremity Peak Torque, Velocity, Power, Fatigue, and Measures of Physical Function in Response to Resistance Training in Older Adults With Limitations in Mobility
The age-related loss in skeletal muscle mass is associated with substantial social and
economic costs as evidenced by impairments in strength, limitations in function, and
ultimately, physical disability and institutionalization (1-3). Improved knowledge of the
physiologic mechanisms that mediate impairments in physical functioning is crucial for
developing effective therapeutic interventions for preserving mobility and independence
among physically frail adults.
To date, pharmacodynamic markers that can be used in a clinical trial in mobility-limited
older adults are limited. Lean body mass measured by dual energy X-ray absorptiometry (DXA)
is frequently used in early phase clinical development of investigational anabolic drugs.
Although increase in muscle mass is considered to contribute to increased muscle strength,
this alone does not completely explain changes in physical performance. Thus, more direct
pharmacodynamic evidence associated with physical functioning is desired in early phase
clinical development decision making. Assessments of muscle power and fatigue can address
this need. The use of such assessments may provide more meaningful information as to the
pharmacodynamics effects of investigational drugs on muscle parameters.
This study will serve as a validation study, aiming to 1) examine the effect a 12-week
resistance program may have on muscle power and fatigue; 2) examine the effect of a 12-week
resistance exercise program on conventional measures of muscle function; 3) determine the
relationship between muscle power/fatigue and conventional measures of physical function.
Data from this study will serve as rationale for potentially including these measures as
pharmacodynamics markers in studies of novel therapies for skeletal muscle loss and/or
weakness.
The age-related loss in skeletal muscle mass is associated with substantial social and
economic costs as evidenced by impairments in strength, limitations in function, and
ultimately, physical disability and institutionalization (1-3). Improved knowledge of the
physiologic mechanisms that mediate impairments in physical functioning is crucial for
developing effective therapeutic interventions for preserving mobility and independence
among physically frail adults.
To date, pharmacodynamic markers that can be used in a clinical trial in mobility-limited
older adults are limited. Lean body mass measured by dual energy X-ray absorptiometry (DXA)
is frequently used in early phase clinical development of investigational anabolic drugs.
Although increase in muscle mass is considered to contribute to increased muscle strength,
this alone does not completely explain changes in physical performance. Thus, more direct
pharmacodynamic evidence associated with physical functioning is desired in early phase
clinical development decision making. Assessments of muscle power and fatigue can address
this need. For example, Bean et al reported that improvements in leg power, independent of
strength, appear to make an important contribution to clinically meaningful improvements in
SPPB (Short Physical Performance Battery) and gait speed (4). Avin and Frey Law performed a
systematic meta-analysis of studies reporting fatigue tasks (voluntary activation) performed
at a relative-intensity in both young (18-45 years of age) and old (>54 years of age)
healthy adults to conclude older adults were able to sustain relative-intensity tasks
significantly longer or with less force decay than younger adults although this age-related
difference was present only for sustained and intermittent isometric contractions and this
age-related advantage was lost for dynamic tasks (5). The use of such assessments may
provide more meaningful information as to the pharmacodynamics effects of investigational
drugs on muscle parameters.
This study will serve as a validation study, aiming to 1) examine the effect a 12-week
resistance program may have on muscle power and fatigue; 2) examine the effect of a 12-week
resistance exercise program on conventional measures of muscle function; 3) determine the
relationship between muscle power/fatigue and conventional measures of physical function.
Data from this study will serve as rationale for potentially including these measures as
pharmacodynamics markers in studies of novel therapies for skeletal muscle loss and/or
weakness.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06396247 -
Impact of Brief Daily Functional Resistance Training on Lower Extremity Physical Performance
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT05975476 -
Comparison of Two Park-Based Activities on Emotional Well-Being in Adults With Mobility Impairments
|
N/A | |
Completed |
NCT01647802 -
Cross-over Study of Three Modular Devices for Aid in Patient Standing and Transfer
|
N/A | |
Completed |
NCT01614392 -
Lower Extremity Muscle and Function in the Elderly: Study 2
|
N/A | |
Enrolling by invitation |
NCT05736484 -
Randomized Clinical Trial to Improve Mobility After Hospitalization
|
N/A | |
Active, not recruiting |
NCT05678985 -
Evaluating Impact and Implementation of Choose to Move (Phase 4)
|
N/A | |
Completed |
NCT06025656 -
Assessment of the Reliability and Validity of the Leg Lateral Reach Test in Adolescent Tennis Players
|
N/A | |
Completed |
NCT04760392 -
Goal-directed Mobilization of Medical Inpatients
|
N/A | |
Enrolling by invitation |
NCT06434298 -
Provincial Scale-up of Choose to Move (CTM) Phase 4
|
N/A | |
Recruiting |
NCT05516030 -
HIFT for People With Mobility-Related Disabilities
|
N/A | |
Not yet recruiting |
NCT06264362 -
Developing a Nonpharmacological Pain Intervention for Community-dwelling Older Adults With Dementia
|
N/A | |
Withdrawn |
NCT04044846 -
Promoting Movement in Older Adults in the Community
|
N/A | |
Terminated |
NCT03558841 -
Effect of Lyra Gait Training on the Mobility of Geriatric Rehabilitation Inpatients
|
N/A | |
Not yet recruiting |
NCT03675490 -
ABLE (Arts-Based Exercise Enhancing LongEvity)
|
N/A | |
Completed |
NCT02913963 -
Changes on Pain and Range of Motion by the Use of Kinesio Taping in Subjects With Myofascial Trigger Point
|
N/A | |
Completed |
NCT02913976 -
Changes on Pain and Range of Motion by the Use of Kinesio Taping in Patients Diagnosed With Cervical Pain
|
N/A | |
Completed |
NCT05081856 -
Use Modular Medical Equipment Vehicle in Mobilization of Patient With Chest Tube
|
N/A | |
Withdrawn |
NCT02298374 -
Evaluation of Homecare Reablement, the Trondheim Model
|
N/A | |
Completed |
NCT02498704 -
Dry Needling and Stretching vs. Stretching Alone on Hamstring Flexibility in Patients With Knee Pain
|
N/A | |
Completed |
NCT00177359 -
Restoring Skill in Walking
|
Phase 2 |